Key result
Obesity and type 2 diabetes were associated with a significantly greater number of CD68+ and CD204+ macrophages in visceral adipose tissue compared to non-obese controls.
Why the study?
Macrophages are implicated in chronic adipose tissue inflammation in obesity, but their functional M1/M2 subtype distribution in relation to type 2 diabetes required evaluation.
Observational (n=116)
No
Obesity and type 2 diabetes are associated with increased macrophage infiltration in visceral adipose tissue, supporting a role for chronic inflammation in these conditions.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; leaves open causal role of macrophage infiltration in obesity and type 2 diabetes.
BACKGROUND AND AIMS: Macrophages are linked to the initiation of the chronic inflammation believed to underlie the changes taking place in the white fatty tissue of obese people. Both the number of macrophages, but their functional status, play an important role in the development of inflammation. Classically, macrophages are divided into two types: pro-inflammatory (M1) and anti-inflammatory (M2) types, and based on current immunological studies, further views on the functional distribution of macrophages are suggested. In this study, we evaluated the M1 and M2 macrophages ratio in obese subjects with, or without diabetes. To identify all macrophages, we used CD68 expression, while CD204 expression is typically used for the M2 macrophage. MATERIALS AND METHODS: During bariatric surgery, carried out in obese people with and without type 2 diabetes (T2D), we obtained subcutaneous adipose tissue from the navel and omental adipose tissue. We also obtained the same tissue from people with a physiological range of BMI from a judicial autopsy. Applying immunohistochemical staining anti-CD68 and anti-CD204, we carried out a quantitative evaluation of the number of macrophages. RESULTS: We found CD68+ and CD204+ positive macrophages in perivascular spaces and between fat cells, both isolated and in larger infiltrates. They were also present in so-called "crown-like structures" (CLS) around dying adipocytes. Quantitative analysis showed an increased number of macrophages in all obese patients compared to the control group of non-obese, individuals without T2D. The most striking observation was the macrophage increase in the visceral fatty tissue of diabetics. The number of CD68 and CD204 positive macrophages was statistically significantly smaller in patients without T2D. CONCLUSION: We demonstrated a significantly greater number of macrophages in visceral adipose tissue, especially in patients with T2D. Our results also show a positive correlation between the presence of T2D and the total number of macrophages; a significantly greater number of macrophages were found in visceral adipose tissue, especially in patients with T2D.
No takes yet. Share an insight, caveat, or question.
Chylíková et al. (2019) conducted an observational in Obesity and Type 2 Diabetes (n=116). Obesity and Type 2 Diabetes vs. Non-obese non-diabetic controls was evaluated on Number of CD68+ and CD204+ macrophages in adipose tissue (p=<0.05). Obesity and type 2 diabetes were associated with a significantly greater number of CD68+ and CD204+ macrophages in visceral adipose tissue compared to non-obese controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: